These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 5166836

  • 21. [Level of free and bound chlorpromazine fractions in the blood and urine during chlorpromazine treatment].
    Nurowska K, Szajbel W, Waszkiewicz E, Welbel L.
    Psychiatr Pol; 1970; 4(4):435-42. PubMed ID: 5472581
    [No Abstract] [Full Text] [Related]

  • 22. Prognosis of schizophrenia before and after pharmacotherapy: II. Three-year follow-up.
    Pritchard M.
    Br J Psychiatry; 1967 Dec; 113(505):1353-9. PubMed ID: 6078489
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [An electrophysiologic study of changes in the functional state of the brains of mental patients following aminazine administration].
    Kopylova TV.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Sep; 69(9):1402-7. PubMed ID: 5364592
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Neuroleptic treatment and negative symptoms in deficit and nondeficit schizophrenia.
    Bustillo JR, Kirkpatrick B, Buchanan RW.
    Biol Psychiatry; 1995 Jul 01; 38(1):64-7. PubMed ID: 7548474
    [No Abstract] [Full Text] [Related]

  • 30. Diagnostic reassessment and treatment response in schizophrenia.
    Honer WG, Smith GN, MacEwan GW, Kopala L, Altman S, Yorkston N, Ehmann TS, Smith A, Lang M.
    J Clin Psychiatry; 1994 Dec 01; 55(12):528-32. PubMed ID: 7814346
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Psychopathology and outcome in first-admission schizophrenia: a 13-year follow-up study at a medical school hospital].
    Kobayashi T.
    Seishin Shinkeigaku Zasshi; 2001 Dec 01; 103(5):383-410. PubMed ID: 11510079
    [Abstract] [Full Text] [Related]

  • 34. Clinical effects of various schedules of medication.
    Chien CP, DiMascio A.
    Behav Neuropsychiatry; 1971 Dec 01; 3(1):5-9. PubMed ID: 5566336
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [A critical study of the influence of negative symptoms on the therapeutic response in schizophrenia].
    Acuña MJ, Martín J, Noval D, Blanco M.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998 Dec 01; 26(4):209-13. PubMed ID: 9807853
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.